Manuel Luedeke

4.5k total citations
18 papers, 562 citations indexed

About

Manuel Luedeke is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Manuel Luedeke has authored 18 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Manuel Luedeke's work include Prostate Cancer Treatment and Research (11 papers), DNA Repair Mechanisms (3 papers) and BRCA gene mutations in cancer (3 papers). Manuel Luedeke is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), DNA Repair Mechanisms (3 papers) and BRCA gene mutations in cancer (3 papers). Manuel Luedeke collaborates with scholars based in Germany, United States and Austria. Manuel Luedeke's co-authors include Christiane Maier, Andres Jan Schrader, Thomas Schnoeller, Julie Steinestel, Konrad Steinestel, Walther Vogel, Antje E. Rinckleb, Josef Hoegel, Marcus V. Cronauer and Jochen K. Lennerz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Epidemiology.

In The Last Decade

Manuel Luedeke

18 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Luedeke Germany 13 321 223 202 100 90 18 562
Kristine M. Wadosky United States 15 236 0.7× 403 1.8× 122 0.6× 96 1.0× 70 0.8× 25 631
André Vasconcelos Portugal 13 128 0.4× 293 1.3× 111 0.5× 153 1.5× 92 1.0× 13 569
Ricardo Chirino Spain 16 62 0.2× 183 0.8× 98 0.5× 103 1.0× 210 2.3× 36 587
Eun-Sil Shelley Hwang United States 9 64 0.2× 156 0.7× 268 1.3× 168 1.7× 54 0.6× 28 650
Pere Galofré Spain 16 64 0.2× 228 1.0× 175 0.9× 82 0.8× 108 1.2× 26 675
Brittany A. Simone United States 11 37 0.1× 215 1.0× 181 0.9× 88 0.9× 27 0.3× 25 457
Elizabeth Nuttall United States 7 179 0.6× 97 0.4× 86 0.4× 71 0.7× 81 0.9× 10 322
Alysia Kern Lovgren United States 6 137 0.4× 171 0.8× 93 0.5× 84 0.8× 69 0.8× 6 501
Alicja Nauman Poland 13 41 0.1× 327 1.5× 153 0.8× 75 0.8× 44 0.5× 23 605

Countries citing papers authored by Manuel Luedeke

Since Specialization
Citations

This map shows the geographic impact of Manuel Luedeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Luedeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Luedeke more than expected).

Fields of papers citing papers by Manuel Luedeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Luedeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Luedeke. The network helps show where Manuel Luedeke may publish in the future.

Co-authorship network of co-authors of Manuel Luedeke

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Luedeke. A scholar is included among the top collaborators of Manuel Luedeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Luedeke. Manuel Luedeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gabriel, Heinz, Sebastiano A. G. Lava, Gian Paolo Ramelli, et al.. (2019). Whole Exome Sequencing Revealed a Candidate Gene for Finkelstein-Seidlmayer Disease. 5(4). 196–196. 3 indexed citations
2.
Kohlsdorf, Katja, Jan‐Bernd Funcke, S. Brandt, et al.. (2018). Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency. International Journal of Obesity. 42(9). 1602–1609. 47 indexed citations
3.
Bens, Susanne, Manuel Luedeke, Tanja Richter, et al.. (2017). Mosaic genome-wide maternal isodiploidy: an extreme form of imprinting disorder presenting as prenatal diagnostic challenge. Clinical Epigenetics. 9(1). 111–111. 8 indexed citations
4.
Surowy, Harald, Dominic Varga, Barbara Burwinkel, et al.. (2017). A low‐frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early‐onset breast cancer (<60 years) and is associated with reduced DNA repair capacity. International Journal of Cancer. 142(4). 757–768. 4 indexed citations
5.
Bernemann, Christof, Thomas Schnoeller, Manuel Luedeke, et al.. (2016). Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. European Urology. 71(1). 1–3. 92 indexed citations
6.
Geybels, Milan S., Joshi J. Alumkal, Manuel Luedeke, et al.. (2015). Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. Clinical Epigenetics. 7(1). 128–128. 30 indexed citations
7.
Wright, Jonathan L., Sarah K. Holt, Daniel W. Lin, et al.. (2015). Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. Prostate Cancer and Prostatic Diseases. 19(1). 53–56. 14 indexed citations
8.
Steinestel, Julie, Manuel Luedeke, Annette Arndt, et al.. (2015). Detecting predictive androgen receptor modifications in circulating prostate cancer cells.. Journal of Clinical Oncology. 33(15_suppl). 5067–5067. 16 indexed citations
9.
Luedeke, Manuel, Antje E. Rinckleb, Suzanne Kolb, et al.. (2015). Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status. American Journal of Epidemiology. 181(9). 706–713. 17 indexed citations
10.
Steinestel, Julie, Manuel Luedeke, Annette Arndt, et al.. (2015). Detecting predictive androgen receptor modifications in circulating prostate cancer cells. Oncotarget. 10(41). 4213–4223. 129 indexed citations
11.
Luedeke, Manuel, Friedemann Zengerling, Felicitas Genze, et al.. (2014). Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells. PLoS ONE. 9(6). e98566–e98566. 23 indexed citations
12.
Maier, Christiane, Kathleen Herkommer, Manuel Luedeke, et al.. (2014). Subgroups of familial and aggressive prostate cancer with considerable frequencies ofBRCA2mutations. The Prostate. 74(14). 1444–1451. 20 indexed citations
13.
Luedeke, Manuel, Natalia Bogdanova, Antje E. Rinckleb, et al.. (2012). Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series. PLoS ONE. 7(3). e34128–e34128. 6 indexed citations
14.
Rinckleb, Antje E., Harald Surowy, Manuel Luedeke, et al.. (2012). The prostate cancer risk locus at 10q11 is associated with DNA repair capacity. DNA repair. 11(8). 693–701. 4 indexed citations
15.
Surowy, Harald, Antje E. Rinckleb, Manuel Luedeke, et al.. (2010). Heritability of baseline and induced micronucleus frequencies. Mutagenesis. 26(1). 111–117. 34 indexed citations
16.
Honold, Lisa, Manuel Luedeke, Rainer Kuefer, et al.. (2009). POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. The Prostate. 70(6). 666–674. 51 indexed citations
17.
Luedeke, Manuel, Matthias D. Hofer, Harald Surowy, et al.. (2009). Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3030–3035. 47 indexed citations
18.
Luedeke, Manuel, Rainer Kuefer, Thomas Paiss, et al.. (2008). Expression changes of CAV1 and EZH2, located on 7q31∼q36, are rarely related to genomic alterations in primary prostate carcinoma. Cancer Genetics and Cytogenetics. 182(2). 103–110. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristine M. Wadosky Breakdown of academic impact, for papers by André Vasconcelos Breakdown of academic impact, for papers by Ricardo Chirino Breakdown of academic impact, for papers by Eun-Sil Shelley Hwang Breakdown of academic impact, for papers by Pere Galofré Breakdown of academic impact, for papers by Brittany A. Simone Breakdown of academic impact, for papers by Elizabeth Nuttall Breakdown of academic impact, for papers by Alysia Kern Lovgren Breakdown of academic impact, for papers by Alicja Nauman
Rankless by CCL
2026